SNY vs TAK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SNY Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) driven by superior Valuation, Growth & Margin while TAK counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, SNY trades at 8.9x Forward P/E with 22.3% operating margin (+15.7% YoY revenue) versus TAK at 12.7x Forward P/E and 16.6% operating margin (+6.7% YoY). In options structure, SNY sits in UNCLASSIFIED (43rd %ile IV; Dealer Gamma Walls on Pro) against TAK sits in UNCLASSIFIED (5th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SNY | TAK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $116.0B | $67.5B | Larger Scale | SNY |
| Trailing P/E Ratio Valuation | 24.1x | N/M | Lower Multiple | SNY |
| Forward P/E Ratio Valuation | 8.9x | 12.7x | Lower Multiple | SNY |
| Revenue Growth (YoY) Growth | +15.7% | +6.7% | Higher Growth | SNY |
| Operating Margin (TTM) Profitability | 22.3% | 16.6% | Higher Margin | SNY |
| Net Profit Margin Profitability | 8.2% | 0.9% | Higher Margin | SNY |
| Return on Equity (ROE) Capital Efficiency | 5.7% | 0.6% | Higher ROE | SNY |
| 52-Week Range Position Momentum | 69% ($39โ$53) | 97% ($14โ$22) | Stronger Trend | TAK |
| Beta / 30D Volatility Risk Regime | 0.20ฮฒ ยท 27% Vol | -0.02ฮฒ ยท 22% Vol | Lower Realized Risk | TAK |
| Unified Institutional Score Composite Signal | 31.7 / 100 (SELL) | 48.0 / 100 (HOLD) | Higher Composite | TAK |